C. FeinLevyMD

Pediatric Hematology & Oncology • New Hyde Park, NY

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Physician

Join to view full profile

Dr. Levy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levy's full profile

Already have an account?

Office
269-01 76th Avenue
Suite 255
New Hyde Park, NY 11040
Phone+1 718-470-3460

Fax+1 718-343-4642

Summary

Dr. Carolyn Fein Levy is a pediatric hematologist/oncologist in New Hyde Park, NY and is affiliated with multiple hospitals in the area, including Steven and Alexandra Cohen Children's Medical Center, Long Island Jewish Medical Center, and North Shore University Hospital. She received her medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 23 years. She also speaks multiple languages, including Hebrew and Spanish. She specializes in pediatric sarcoma oncology and pediatric solid tumor oncology.

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1997 - 2000
Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1994 - 1997
Icahn School of Medicine at Mount SinaiClass of 1994

Certifications & Licensure

NY State Medical License 1995 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Recruiting
Phase 2, Phase 3
Roles: Contact
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis Start of enrollment: 2021 Jul 13
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Sa...
Sameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, Barbara Spitzer, Carolyn Fein Levy
Pediatric Blood & Cancer. 2024-11-01
1 citations
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Deevyashali Parekh, Howard Lin, Akanksha Batajoo, Erin Peckham-Gregory, Vivekanudeep Karri
British Journal of Haematology. 2024-05-01
Oral sirolimus for the treatment of juvenile xanthogranuloma: Report of two pediatric cases.
Michelle Toker, Fatema Esaa Hassonjee, John Amodio, Morris C Edelman, Kristina I Emeghebo
Pediatric Dermatology. 2024-03-05

Other Languages

Hebrew, Spanish